Stock comparison
Side-by-side financials for CTKB and ILMN. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ILMN is larger
Market cap data is available for the leading company in this comparison.
Market value leader
ILMN
Latest market capitalization comparison.
Revenue leader
ILMN
CTKB: $201.49M vs ILMN: $4.34B.
Profit leader
ILMN
CTKB: -$66.54M vs ILMN: $850.00M.
Margin leader
ILMN
CTKB: -33.0% vs ILMN: 19.6% net margin.
| Metric | CTKB | ILMN |
|---|---|---|
| Market cap | - | $28.78 B |
| US-listed rank | - | #485 |
| Revenue (latest FY) | $201.49M | $4.34B |
| Net income (latest FY) | -$66.54M | $850.00M |
| Net margin | -33.0% | 19.6% |
| P/E (trailing FY) | - | 33.9x |
| SEC filings | 432 | 3,713 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, Cytek Biosciences, Inc. reported $201.49M in revenue while ILLUMINA, INC. reported $4.34B.
Full pages: Cytek Biosciences, Inc. and ILLUMINA, INC., or browse the full rankings.